Listen " Celine Martin discusses atrial fibrillation, neurovascular and where J&J Medtech may be going next "
Episode Synopsis
In this episode, Celine Martin, company group chairman, Cardiovascular & Specialty Solutions Group, offers insights from her career at Johnson & Johnson. What are the four variables you need to consider to thrive in a global company. Martin also shares insights on cardiac ablation, neurovascular, and where the company is headed following the acquisition of Abiomed.
Paul Grand, CEO of Medtech Innovator, joins as a co-host offering insights on Chris Newmarker’s Newsmakers – Moon Surgical, Butterfly Network, Medtronic, Avail Medsystems, Dexcom, and Fresenius Medical. Grand shares a personal connection to one of the companies.
Grand, Newmarker and Tom Salemi also share their thoughts on the retirement of Mike Mussallem, CEO of Edwards Lifesciences.
Thank you to Nordson Medical for sponsoring this episode. Go to NordsonMedical.com for more information.
Thank you for listening to the DeviceTalks Weekly Podcast
You can subscribe to this podcast on any major podcast player.
More episodes of the podcast DeviceTalks Podcast Network
May the best robot win – Medtronic’s Hugo RAS ready to compete for surgical business in the US
19/12/2025
Ray Cohen on How to Successfully Build and Exit a MedTech; Talking Revolution with Sarah Matt, MD
12/12/2025
How Enovis is unlocking better bracing with innovative materials, patient comfort & next-gen tech
09/12/2025
How amazing tech – like Medtronic’s LINQ and beyond – can, will and must change health care
05/12/2025
Where is surgical robotics headed? Listen to these leaders- Moon’s Osdoit, Intuitive’s Jeddi
26/11/2025
J&J’s Schmid, Stanford’s Makower on helping MedTech find a higher gear for innovation and growth
21/11/2025
How Enovis is accelerating orthopedic recovery with bone stimulation and patient-centered innovation
18/11/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.